Navigation Links
Life Technologies Announces Fourth Quarter and Fiscal 2012 Results

set impairments, and in process research and development expenses, incurred as a result of business combinations as well as the impact from the divestiture and discontinuance of product lines.  The Company also excludes noncash interest expense associated with convertible debt bifurcation and noncash charges associated with non-controlling interests. In addition, the Company excludes one-time costs including the early repayment of debt and the associated impacts, and the impact of certain settlements in order to provide a supplemental comparison of the results of operations.  LIFE TECHNOLOGIES CORPORATIONCONSOLIDATED STATEMENTS OF OPERATIONSFor the yearFor the year(in thousands, except per share data)ended December 31, 2012ended December 31, 2011(unaudited)Revenues$
3,775,672Cost of revenues

1,372,2771,356,967Purchased intangibles amortization

291,756308,728Gross profit

2,134,4772,109,977Gross margin56.2%55.9%Operating expenses:Selling, general and administrative

1,054,6161,008,973Research and development

341,892377,924Business consolidation costs

72,73275,324Total operating expenses

1,469,2401,462,221Operating income

665,237647,756Operating margin

17.5%17.2%Interest income

2,4013,932Interest expense

(123,915)(162,073)Other expense, net

(11,898)(10,913)Total other expense, net

(133,412)(169,054)Income from operations before provision for income taxes

531,825478,702Income tax provision

(101,376)(100,868)Net income

430,449377,834Net loss attributable to non-controlling interests

406658Net income attributable to controlling interest$
378,492Effective tax rate 

19.1%21.1%Add back interest expense for subordinated

SOURCE Life Technologies Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related biology technology :

1. Palatin Technologies, Inc. to Report Fiscal Year 2012 First Quarter Results; Teleconference and Webcast to be held on November 15, 2011
2. UV Flu Technologies Expands Its International Footprint
3. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011
4. OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy
5. Hologic to Showcase 3D Mammography (Breast Tomosynthesis) and Other Advanced Womens Imaging Technologies at RSNA 2011, the Largest Radiology Show in the World
6. Modern Mobility Aids, Inc. Secures Financing to Close Acquisition Agreement of LumiGene Technologies
7. Senesco Technologies, Inc. to Webcast, Live, at on December 1st
8. Animal Biotechnology - Technologies, Markets and Companies
9. Gene Therapy - Technologies, Markets and Companies
10. Biomarkers - Technologies, Markets and Companies
11. Palatin Technologies to Present at Windhovers Therapeutic Area Partnerships Conference
Post Your Comments:
(Date:1/23/2015)... 2015  Array BioPharma Inc. (NASDAQ: ARRY ) ... with Novartis Pharma AG to acquire worldwide rights to ... development.  This agreement is conditional on the closing of transactions ... 2014, which are expected to close in the first ...
(Date:1/22/2015)... 2015 Shimadzu Scientific Instruments today ... UV-visible spectrophotometer. Offering wavelength scanning from 190 to ... for applications in a variety of industries, including ... user-friendly UV-1280 enables intuitive operation, while the enhanced ...
(Date:1/22/2015)... | RBJ today announces the firm brokered a long-term lease ... leading biopharmaceutical company, at Two Ledgemont Center in ... , president, and Brian Cohen , senior vice president, ... at 95 Hayden Ave. Photo - ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Protocol Networks ... The growing team of brand-neutral, independent consultants, Protocol Networks ... Rogers explained that over the years, his company has ... Moroso, Town of Plainfield, as well as others. With ...
Breaking Biology Technology:Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 2Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 3Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 4Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 5Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 6Array Announces Agreement To Acquire ENCORAFENIB (LGX818) 7Shimadzu’s New Monitored Single-Beam UV-Vis Spectrophotometer Offers Comprehensive Measurement Options in a Compact Body 2Transwestern?RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Protocol Networks Brings Independent Technology Consulting to the Constitution State 2
... Care at Hahnemann among the Best in the Nation ... it has been granted Magnet(R) recognition by the American Nurses ... the highest levels of recognition a hospital or medical center ... hospitals in the country that have achieved this prestigious distinction. ...
... , , , WALTHAM, Mass., Dec. 16 Decision ... firms for pharmaceutical and healthcare issues, finds that, according ... and Abbott,s briakinumab (both interleukin inhibitors) will capture 22 ... drug market for moderate to severe psoriasis. Among these ...
... Looking ... for! Zap-CHO is a robust CHO cell culture media supplement that improves the growth ... Zap-CHO is an animal free, well defined and consistent recombinant CHO supplement. , ... Fort Collins, CO (PRWEB) ...
Cached Biology Technology:Hahnemann University Hospital Granted Magnet(R) Status 2Hahnemann University Hospital Granted Magnet(R) Status 3In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2
(Date:12/17/2014)... 2014 The Defense Logistics Agency is insourcing its ... counterfeit microcircuits from entering into its supply chain. ... anti-counterfeit initiative dubbed DNA marking. The capability will validate ... throughout the supply chain. The new quality control measures ...
(Date:12/17/2014)... N.C. , Dec. 16, 2014 Valencell, a ... its PerformTek biometric technology to industry leaders such as ... accurate, clinically validated, biometric wearable products. These products will ... in Las Vegas . ...
(Date:12/17/2014)... fundamentally transforming the travel experience and nowhere is this ... decade, ePassports, biometric readers, and secure document scanners have ... via eGates and Automated Passport Control (APC) Kiosks at ... across the globe. According to ...
Breaking Biology News(10 mins):Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
... women have twice the risk of preterm delivery than ... a new study by the Kaiser Permanente Division of ... University Press,s journal Human Reproduction on behalf ... The study found that pregnant women with symptoms ...
... Palm Vein Authentication Technology Integrates with,Citrix Password ... and,Compliance, SUNNYVALE, Calif., Oct. 22 ... supplier of innovative computer products including,hard disk ... that its PalmSecure LOGONDIRECTOR has been verified ...
... University, along with colleagues from the California Institute of ... other institutions, have unearthed crystalline magnetic fossils of a ... boundary of the Paleocene and Eocene epochs, some 55 ... in the Proceedings of the National Academy of ...
Cached Biology News:Depression during pregnancy can double risk of preterm delivery 2Fujitsu PalmSecure LOGONDIRECTOR Verified as Citrix Ready 2Fujitsu PalmSecure LOGONDIRECTOR Verified as Citrix Ready 3Fujitsu PalmSecure LOGONDIRECTOR Verified as Citrix Ready 4Earlier global warming produced a whole new form of life 2
The large Dodeca stainer shaking rack holds the staining trays in the large Dodeca stainer....
... BioLegend, the Quansys Biosciences Q-Plex Array is ... cytokines/chemokines for human, mouse, and rat research. ... fully quantitative ELISA-based test where 4 distinct ... well of a 96-well plate in a ...
Biology Products: